Newsbenzinga
Rapport Therapeutics Prices Separate Offerings Of ~$175M Of Stock At $21.00/Share, Warrants To Purchase Up To ~$25M Of Stock At $20.999 Per Pre-Funded Warrant, And $150M Of 2.25% Convertible Senior Notes Due 2032
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…